William Zeitler
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC) (NCT06083454) | William Zeitler | 2023-10-23 |
Track William Zeitler automatically
Every clearance here is in the API, with alerts when new ones post.